# Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders

> **NCT02824627** · PHASE2 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 58 (actual)

## Conditions studied

- Mood Disorder
- Disruptive Behavior Disorders

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02824627
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-27
- **Primary completion:** 2021-08-10
- **Final completion:** 2021-08-10
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2023-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02824627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02824627, "Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02824627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*